Schizophrenia Patients Clinical Trial
A Phase I, Drug-Drug Interaction Study between Midazolam and Lurasidone HCl.
lurasidone 120 mg, midazolam 5 mg
To compare the single-dose pharmacokinetic profile of midazolam 5 mg when administered alone
vs. when administered with a single-dose of lurasidone 120 mg.
To compare the single dose pharmacokinetic profile of midazolam 5 mg when administered alone
vs. when administered after steady state dosing with lurasidone 120 mg.
;
Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04572685 -
Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection in Schizophrenia Patients
|
Phase 1 |